We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Astellas Pharma Inc | TG:YPH | Tradegate | Ordinary Share |
| Price Change | % Change | Share Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|
| 0.174 | 1.84% | 9.648 | 1,110 | 14:12:31 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 9.532 | 9.648 | 9.648 | 9.362 | 9.362 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| - |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 12:00:00 | 266 | 9.648 | EUR |
| Date | Time | Source | Headline |
|---|---|---|---|
| 22/4/2024 | 19:41 | ALNC |  Takeda, Astellas and Sumitomo to create new drug discovery company |
| 11/3/2024 | 15:37 | ALNC | IN BRIEF: Astellas receives FDA exclusivity approval for Cresemba |
| 11/3/2024 | 13:16 | ALNC | *Astellas: FDA grants drug exclusivity to Cresemba aspergillosis,.. |
| 20/2/2024 | 21:15 | ALNC | Merck and Astellas drugs get priority review in US and Japan |
Astellas Pharma (YPH) Share Charts1 Year Astellas Pharma Chart |
|
1 Month Astellas Pharma Chart |
Intraday Astellas Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
